Golay KP - Search Results

1

CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter gene.

Eap CB, Fellay J, Buclin T, Bleiber G, Golay KP, Brocard M, Baumann P, Telenti A. Eap CB, et al. Among authors: golay kp. Pharmacogenetics. 2004 Apr;14(4):255-60. doi: 10.1097/00008571-200404000-00005. Pharmacogenetics. 2004. PMID: 15083070

2

Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

Eap CB, Buclin T, Cucchia G, Zullino D, Hustert E, Bleiber G, Golay KP, Aubert AC, Baumann P, Telenti A, Kerb R. Eap CB, et al. Among authors: golay kp. Eur J Clin Pharmacol. 2004 Jun;60(4):237-46. doi: 10.1007/s00228-004-0762-z. Epub 2004 Apr 28. Eur J Clin Pharmacol. 2004. PMID: 15114429 Clinical Trial.

3

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects.

Eap CB, Buclin T, Hustert E, Bleiber G, Golay KP, Aubert AC, Baumann P, Telenti A, Kerb R. Eap CB, et al. Among authors: golay kp. Eur J Clin Pharmacol. 2004 Jun;60(4):231-6. doi: 10.1007/s00228-004-0767-7. Epub 2004 Apr 28. Eur J Clin Pharmacol. 2004. PMID: 15114431 Clinical Trial.

4

Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.

Fellay J, Marzolini C, Decosterd L, Golay KP, Baumann P, Buclin T, Telenti A, Eap CB. Fellay J, et al. Among authors: golay kp. Eur J Clin Pharmacol. 2005 Feb;60(12):865-73. doi: 10.1007/s00228-004-0855-8. Epub 2005 Jan 19. Eur J Clin Pharmacol. 2005. PMID: 15657782 Clinical Trial.

5

In vitro P-glycoprotein-mediated transport of (R)-, (S)-, (R,S)-methadone, LAAM and their main metabolites.

Crettol S, Digon P, Golay KP, Brawand M, Eap CB. Crettol S, et al. Among authors: golay kp. Pharmacology. 2007;80(4):304-11. doi: 10.1159/000107104. Epub 2007 Aug 9. Pharmacology. 2007. PMID: 17690563

6

Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.

Shinderman M, Maxwell S, Brawand-Amey M, Golay KP, Baumann P, Eap CB. Shinderman M, et al. Among authors: golay kp. Drug Alcohol Depend. 2003 Mar 1;69(2):205-11. doi: 10.1016/s0376-8716(02)00320-4. Drug Alcohol Depend. 2003. PMID: 12609702

7

Increase of oral methadone dose in methadone injecting patients: a pilot study.

Eap CB, Felder C, Golay KP, Uehlinger C. Eap CB, et al. Among authors: golay kp. J Addict Dis. 2003;22(3):7-17. doi: 10.1300/J069v22n03_02. J Addict Dis. 2003. PMID: 14621341

8

Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.

Bart PA, Rizzardi PG, Gallant S, Golay KP, Baumann P, Pantaleo G, Eap CB. Bart PA, et al. Among authors: golay kp. Ther Drug Monit. 2001 Oct;23(5):553-5. doi: 10.1097/00007691-200110000-00010. Ther Drug Monit. 2001. PMID: 11591903

9

Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers.

Begré S, von Bardeleben U, Ladewig D, Jaquet-Rochat S, Cosendai-Savary L, Golay KP, Kosel M, Baumann P, Eap CB. Begré S, et al. Among authors: golay kp. J Clin Psychopharmacol. 2002 Apr;22(2):211-5. doi: 10.1097/00004714-200204000-00017. J Clin Psychopharmacol. 2002. PMID: 11910269

10

Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.

Jaquenoud Sirot E, Harenberg S, Vandel P, Lima CA, Perrenoud P, Kemmerling K, Zullino DF, Hilleret H, Crettol S, Jonzier-Perey M, Golay KP, Brocard M, Eap CB, Baumann P. Jaquenoud Sirot E, et al. Among authors: golay kp. J Clin Psychopharmacol. 2012 Oct;32(5):622-9. doi: 10.1097/JCP.0b013e3182664d98. J Clin Psychopharmacol. 2012. PMID: 22926595 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters